The many faces of SMN: deciphering the function critical to spinal muscular atrophy pathogenesis

被引:23
|
作者
Boyer, Justin G. [1 ,2 ]
Bowerman, Melissa [1 ,2 ]
Kothary, Rashmi [1 ,2 ,3 ]
机构
[1] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada
[2] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada
[3] Univ Ottawa, Dept Med, Ottawa, ON, Canada
关键词
actin dynamics; neurodegeneration; preclinical models; snRNP assembly; spinal muscularatrophy; survival motor neuron;
D O I
10.2217/FNL.10.57
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinal muscular atrophy (SMA) is the leading genetic cause of infant death, affecting 1 in 6000-10,000 live births. SMA is an autosomal recessive disorder characterized by the degeneration of a-motor neurons, and lower limb and proximal muscle weakness and wasting. SMA is the result of the deletion of or mutations in the survival motor neuron (SMN) 1 gene. Currently, our understanding of how loss of the widely expressed SMN leads to the selective pathogenesis observed in SMA is limited. Here, we discuss the known nuclear and cytoplasmic functions of the SMN protein and how they relate to the SMA pathology reported in motor neurons, striated muscle and at neuromuscular junctions. While a vast amount of work in various cell and animal models has increased our knowledge of the many functions of the SMN protein, we have yet to come to a full understanding of which role(s) are central to SMA pathogenesis.
引用
收藏
页码:873 / 890
页数:18
相关论文
共 50 条
  • [41] SMN dosage analysis and risk assessment for spinal muscular atrophy -: Reply
    Feldkötter, M
    Schwarzer, V
    Wirth, R
    Wienker, TF
    Wirth, B
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (06) : 1598 - 1599
  • [42] Spinal muscular atrophy carriers with two SMN1 copies
    Rochmah, Mawaddah Ar
    Awano, Hiroyuki
    Awaya, Tomonari
    Harahap, Nur Imma Fatimah
    Morisada, Naoya
    Bouike, Yoshihiro
    Saito, Toshio
    Kubo, Yuji
    Saito, Kayoko
    Lai, Poh San
    Morioka, Ichiro
    Iijima, Kazumoto
    Nishio, Hisahide
    Shinohara, Masakazu
    BRAIN & DEVELOPMENT, 2017, 39 (10): : 851 - 860
  • [43] Analysis of the SMN and NAIP genes in Slovak spinal muscular atrophy patients
    Zat'ková, A
    Hahnen, E
    Wirth, B
    Kádasi, L
    HUMAN HEREDITY, 2000, 50 (03) : 171 - 174
  • [44] THERAPEUTICS THAT DIRECTLY INCREASE SMN EXPRESSION TO TREAT SPINAL MUSCULAR ATROPHY
    Shababi, Monir
    Mattis, Virginia B.
    Lorson, Christian L.
    DRUG NEWS & PERSPECTIVES, 2010, 23 (08) : 475 - 482
  • [45] Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients
    Christina Brahe
    Tiziana Vitali
    Francesco D Tiziano
    Carla Angelozzi
    Anna Maria Pinto
    Federica Borgo
    Umberto Moscato
    Enrico Bertini
    Eugenio Mercuri
    Giovanni Neri
    European Journal of Human Genetics, 2005, 13 : 256 - 259
  • [46] Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy
    Shin, S
    Park, SS
    Hwang, YS
    Lee, KW
    Chung, SG
    Lee, YJ
    Park, MH
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (01) : 93 - 98
  • [47] Controlled Induction of SMN in the Mouse, a New Model for Spinal Muscular Atrophy
    Hammond, Suzan M.
    Gogliotti, Rocky G.
    Rao, Vamshi K.
    DiDonato, Christine J.
    MOLECULAR THERAPY, 2009, 17 : S249 - S250
  • [48] Deletions in the SMN and NAIP genes in patients with spinal muscular atrophy in Croatia
    Sertic, J
    Barisic, N
    Sostarko, M
    Bosnjak, N
    Culic, V
    Cvitanovic, L
    Ferencak, G
    Brzovic, Z
    Stavljenic-Rukavina, A
    COLLEGIUM ANTROPOLOGICUM, 1997, 21 (02) : 487 - 492
  • [49] Neurodevelopmental Consequences of Smn Depletion in a Mouse Model of Spinal Muscular Atrophy
    Liu, Hong
    Shafey, Dina
    Moores, Justin N.
    Kothary, Rashmi
    JOURNAL OF NEUROSCIENCE RESEARCH, 2010, 88 (01) : 111 - 122
  • [50] AAV-mediated augmentation of SMN levels for spinal muscular atrophy
    Cheng, S. H.
    Passini, M. A.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 650 - 650